Evidence map›Paper›PMID 12082616›Full record

ArticleOncogene2002

Expression and transactivating functions of the bZIP transcription factor GADD153 in mammary epithelial cells.

Amjad H Talukder, Rui-An Wang, Rakesh Kumar

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Review
  3. Molecules and cells · 2020
    Article
  4. Article
  5. Review
  6. Article
  7. Scotin: A new p63 target gene expressed during epidermal differentiation.Biochemical and biophysical research communications · 2008
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Roles for neuregulins in human cancer.Clinical & experimental metastasis · 2004
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Amjad H TalukderDepartment of Molecular and Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas, TX 77030, USA.
Rui-An Wang
Rakesh Kumar
The University of Texas MD Anderson Cancer Center · USMelanoma Institute Australia · AU

Funding

Pak1 - PIN Pathway in Breast Cancer ProgressionR01CA080066 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 1999 to 2008
$2.3M
RECEPTOR BLOCKADE FOR BREAST CANCERR01CA065746 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 1999 to 2007
$1.9M
LABORATORY STUDY OF CHEMOTHERAPY PLUS RECEPTOR BLOCKADEU01CA065746 · NCI · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI KUMAR, RAKESH · 1995 to 1998
–
NCI NIH HHS CA65746NCI NIH HHS CA80066
6 · The paper itself

Abstract

Heregulin-beta1 (HRG), a combinatorial ligand for human epidermal growth factor receptor 3 (HER3) and HER4, is a regulatory polypeptide having distinct biological effects, such as growth stimulation, differentiation, invasiveness, and migration in mammary epithelial cells. The mechanism underlying the diverse functions of HRG is not well established but is believed to depend on induced changes in the expression of specific cellular gene products, their modification, or both. Here, we identified the basic leucine zipper transcription factor, the growth-arrest and DNA-damage 153 (GADD153)/CCAAT-enhancer binding protein (C/EBP) homologous protein (CHOP) as one of the HRG-inducible genes. We demonstrated that HRG stimulation of mammary epithelial cells induces the expression of GADD153 mRNA and protein and transcription of GADD153 promoter. The transcriptional activity of the GADD153 promoter as well as transcription from the C/EBP-activating transcription factor (ATF) composite motif in the GADD153 promoter was also stimulated by HRG-inducible ATF-4 and activated HER2 but not wild-type HER2. GADD153 expression was upregulated by the lactogenic hormones insulin and progesterone and associated with differentiation of normal mammary epithelial cells. Consistent with its role as transcriptional modifier, GADD153 stimulated transcription of beta-casein promoter activity in a STAT5a-sensitive manner in mammary epithelial cells. Analysis of mouse mammary gland development revealed that GADD153 expression was predominantly restricted in the early lactating stages. Because cyclic AMP responsive element and ATF binding sites are present in a variety of growth-regulating cellular genes, these findings suggest that stimulation of GADD153 expression and its transactivating functions may constitute an important mechanism of regulation of putative genes having diverse functions during cell growth and differentiation.

Indexed as

Milk ProteinsActivating Transcription Factor 4AdenocarcinomaAnimalsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedBreastBreast NeoplasmsCaseinsCCAAT-Enhancer-Binding ProteinsCell DifferentiationCell DivisionCells, CulturedCyclic AMPDNA-Binding ProteinsEpithelial CellsActivating Transcription Factor 4Antibodies, MonoclonalAntibodies, Monoclonal, HumanizedATF4 protein, humanCaseinsCCAAT-Enhancer-Binding ProteinsCyclic AMPDDIT3 protein, humanDdit3 protein, mouseDNA-Binding ProteinsErb-b2 Receptor Tyrosine KinasesInsulinMilk ProteinsNeuregulin-1ProgesteroneSTAT5A protein, humanStat5a protein, mouseSTAT5 Transcription FactorTrans-ActivatorsTranscription Factor CHOPTranscription FactorsTrastuzumabTumor Suppressor Proteins

Identifiers

PMID12082616
OpenAlexW2014028065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.